Results
|
9341.
|
|
|
9342.
|
|
|
9343.
|
|
|
9344.
|
|
|
9345.
|
Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessment. [electronic resource] by
- Currier, Jeffrey R
- Galley, Lynee M
- Wenschuh, Holger
- Morafo, Vivian
- Ratto-Kim, Silvia
- Gray, Clive M
- Maboko, Leonard
- Hoelscher, Michael
- Marovich, Mary A
- Cox, Josephine H
Producer: 20080311
In:
Clinical and vaccine immunology : CVI vol. 15
Availability: No items available.
|
|
9346.
|
|
|
9347.
|
|
|
9348.
|
|
|
9349.
|
|
|
9350.
|
|
|
9351.
|
|
|
9352.
|
|
|
9353.
|
|
|
9354.
|
|
|
9355.
|
Detection, identification and quantification of a new de-fluorinated impurity in casopitant mesylate drug substance during late phase development: an analytical challenge involving a multidisciplinary approach. [electronic resource] by
- Turco, Lucilla
- Provera, Stefano
- Curcuruto, Ornella
- Bernabè, Elena
- Nicoletti, Anna
- Martini, Luca
- Castoldi, Damiano
- Cimarosti, Zadeo
- Papini, Damiano
- Marchioro, Carla
- Dams, Riet
Producer: 20110110
In:
Journal of pharmaceutical and biomedical analysis vol. 54
Availability: No items available.
|
|
9356.
|
|
|
9357.
|
Infusion fluids contain harmful glucose degradation products. [electronic resource] by
- Bryland, Anna
- Broman, Marcus
- Erixon, Martin
- Klarin, Bengt
- Lindén, Torbjörn
- Friberg, Hans
- Wieslander, Anders
- Kjellstrand, Per
- Ronco, Claudio
- Carlsson, Ola
- Godaly, Gabriela
Producer: 20101008
In:
Intensive care medicine vol. 36
Availability: No items available.
|
|
9358.
|
|
|
9359.
|
|
|
9360.
|
|